PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12052823-8	2002	Treatment with two pharmacological inhibitors of NF-kappa B, SN50 and N-tosyl-l-phenylalanine chloromethyl ketone (TPCK), blocks TNF-induced Akt activation.	Tosylphenylalanyl Chloromethyl Ketone	70-113	tumor necrosis factor	Mus musculus	129-132	
11526436-8	2001	Both TNF-induced necrosis and necrosis induced by anti-Fas in the presence of the caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone are prevented by the serine protease inhibitor N-tosyl-L-phenylalanine chloromethylketone and the oxygen radical scavenger butylated hydroxyanisole, while Fas-induced apoptosis is not affected.	Tosylphenylalanyl Chloromethyl Ketone	201-243	tumor necrosis factor	Mus musculus	5-8	
9415036-0	1997	Tosylphenylalanine chloromethyl ketone inhibits TNF-alpha mRNA synthesis in the presence of activated NF-kappa B in RAW 264.7 macrophages.	Tosylphenylalanyl Chloromethyl Ketone	0-38	tumor necrosis factor	Mus musculus	48-57	
9415036-1	1997	Serine proteinase inhibitors such as N-tosyl-L-phenylalanine chloromethyl ketone (TPCK) and N alpha-p-tosyl-L-lysine chloromethyl ketone (TLCK) were shown to inhibit production of tumour necrosis factor-alpha (TNF-alpha) in lipopolysaccharide (LPS)-activated RAW 264.7 macrophages.	Tosylphenylalanyl Chloromethyl Ketone	37-80	tumor necrosis factor	Mus musculus	210-219	
9367540-4	1997	N-tosyl-l-phenylalanine chloromethyl ketone and Nalpha-p-tosyl-l-lysine chloromethyl ketone, two serine protease inhibitors, has a protective effect on TNF-induced killing, while Fas-mediated cell death was rather enhanced.	Tosylphenylalanyl Chloromethyl Ketone	0-43	tumor necrosis factor	Mus musculus	152-155